HOME >> MEDICINE >> NEWS
Mostly In The Mind

The benefits of antidepressant drugs could be almost entirely due to the psychological boost derived from taking a pill rather than their effects on brain chemistry, say two researchers in the US.

Irving Kirsch of the University of Connecticut and Guy Sapirstein of Westwood Lodge Hospital, Needham, analysed 19 studies on selected antidepressants and sedatives-including tricyclics and the newer Prozac-type drugs-involving 2318 patients. In each study, the patients had been given either an active drug or a chemically inactive placebo, and their psychological conditions had been evaluated at the beginning and end.

Pharmaceuticals companies claim that antidepressants are 40 percent more effective than placebos. But Kirsch and Sapirstein found that the drugs were only 25 percent more effective. In addition, they suggest that even that 25 percent could be due to an additional placebo effect derived from the side effects caused by the antidepressants, which alerted patients to the fact that they were receiving an active drug rather than a placebo. They say that the studies could have wrongly ascribed this additional effect to a chemical change induced by the drugs.

Their analysis also suggests that antidepressants offer no advantage over drugs such as anxiolytics and tranquillisers, which adds fuel to the suspicion that the newer antidepressants are not as specific in their actions as their manufacturers claim.

Simon Wessely, professor of psychiatry at King's College London, agrees. "There's tremendous uncertainty about how they work," he says. "The public thinks the doctors know, but they don't. Any decent psychopharmacologist will tell you this."

Wessely says Kirsch and Sapirstein are right to point out that side effects can alert a patient in a trial to the fact they are getting an active drug rather than a placebo. "If patients know they're getting treatment, their expectation will be raised and with it their
'"/>

Contact: Celia Thomas
claire.bowles@rbi.co.uk
44 171 331 2751
New Scientist
8-Jul-1998


Page: 1 2

Related medicine news :

1. Female Soccer Players Perform Best On A High-Fat Diet, UB Study Finds
2. Study of energy and health in Africa focuses spotlight on charcoal and forest management
3. Study shows promise in identifying kidney failure
4. Study shows patch therapy may be as effective as oral medications
5. Study shows soy is well accepted in school lunches
6. Study finds that coordinating care of chronically ill patients does not increase liability
7. Study provides new estimates of the causes of child mortality worldwide
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mostly The Mind

(Date:5/24/2013)... Let’s face it: very few are luckily gifted ... majority of people to be uncomfortable with the color of ... addiction or simply genetics, yellowish or stained teeth suppresses confidence ... , Herald Square Dental is proud to announce the ... White Max. , Teeth become discolored for a number ...
(Date:5/24/2013)... Chino, CA (PRWEB) May 24, 2013 Area ... huge selection of new hot tubs to choose from at ... Super Sale . The sales event takes place at ... May 26, 2013. , Jacuzzi, the industry's leading hot ... sale traveling across the country. The event will feature popular ...
(Date:5/24/2013)... 24, 2013 The nation’s first trial ... Surgical Inc.’s da Vinci Surgical System concluded yesterday, Bernstein ... Washington State Court jury ruled in a 10-to-2 decision ... surgeon who performed a da Vinci prostatectomy on a ... family had alleged in their lawsuit that the da ...
(Date:5/24/2013)... of infantile myofibromatosis (IM)a disorder characterized by multiple tumors ... therapeutic targets, according to researchers from the Icahn School ... the American Journal of Human Genetics , may ... for which the only current treatment option is repeated ... inheritied disorder that develops in infancy or even in ...
(Date:5/24/2013)... 24, 2013 BestSatelliteProviders.com the online ... thousands of consumers compare the features and services ... site recently released the rankings of the best ... available for viewing on their website. , ... According to Adam Matthews, the spokesperson for BestSatelliteProviders.com, ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2
(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately.  Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
Cached News: